Sbiomedics
Business Services · South Korea · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Woo-il Venture Town 28 Seongsu 2-ro 26-g...Website
www.sbiomedics.comRevenue
<$5 MillionIndustry
About Sbiomedics
Sbiomedics Org Chart
Is Sbiomedics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Sbiomedics, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Sbiomedics launches new products
Check if Sbiomedics has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Sbiomedics has new funding data
Click to see if Sbiomedics had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Sbiomedics
Check out if Sbiomedics is spiking on competitors!
Earning: See what the market has to say on Sbiomedics recently announced quarterly report
Recommended Actions
Reach out to Masked Content who joined Sbiomedics as Masked Content
Find more new buyers
Company Profile Activity
Activity Insights
Sbiomedics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Sbiomedics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Sbiomedics.
Sbiomedics Tech Stack
A closer look at the technologies used by Sbiomedics
Sbiomedics News & Media
S.BIOMEDICS Investigational Cell Therapy for Parkinson’s Disease With TED-A9 Shows Positive Data at 12-months in Phase 1/2a Clinical Trial
SEOUL, South Korea--(BUSINESS WIRE)-- #CellTherapy--S.BIOMEDICS reported that TED-A9, an investigational cell therapy for Parkinson's disease, showed positive data during the Phase 1/2a trial.S.BIOMEDICS Dopamine Cell Therapy for Parkinson’s Disease with TED-A9 Shows Promising Results at 12 months in Phase I/IIa Clinical Trial
SEOUL, South Korea--(BUSINESS WIRE)-- #ClinicalTrials--S.BIOMEDICS announces positive one-year assessment data f of Phase I/IIa clinical trial for Parkinson’s disease with TED-A9.S.BIOMEDICS completes brain transplant of hESC-derived dopaminergic progenitors (TED-A9) for Phase 1/2a study in patients with Parkinson’s disease
SEOUL, South Korea--(BUSINESS WIRE)-- #BrainTransplant--S.BIOMEDICS successfully completed phase 1/2a clinical trial of TED-A9 on actual middle-aged Parkinson's patients.
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Sbiomedics
Sbiomedics is a company that operates in the Research & Development industry. It employs 10to19 people and has 1Mto5M of revenue. The company is headquartered in Seoul Special City, South Korea.... Read More
